Biological characteristics of genetic variants of Urabe AM9 mumps vaccine virus

Virus Research

Volumn 67, Issue 1, 2000, Pages 49-57

  Wright, Kathryn E ^a   Dimock, Kenneth ^a   Brown, Earl G ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

HN gene; Mumps virus; Vaccine strain

Indexed keywords

MUMPS VACCINE; VIRUS SIALIDASE;

ANIMAL CELL; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME ACTIVITY; GENETIC VARIABILITY; IN VITRO STUDY; MUMPS VIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VERO CELL; VIROGENESIS; VIRUS CHARACTERIZATION; VIRUS ISOLATION;

MUMPS VIRUS;

EID: 0034115633     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(00)00129-5     Document Type: Article

References (30)

1. Afzal M.A., Pickford A.R., Yates P.J., Forsey T., Minor P.D. Matrix protein gene sequence of vaccine and vaccine-associated strains of mumps virus. J. Gen. Virol. 75:1994;1169-1172.
2. Afzal M.A., Yates P.J., Minor P.D. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. J. Infect. Dis. 177:1998;265-266.
3. Afzal M.A., Marsden S.A., Hull R.M., Pipkin P.A., Bentley M.L., Minor P.L. Evaluation of the neurovirulence test for mumps vaccines. Biologicals. 27:1999;43-49.
4. Belshe R.B., Hissom F.K. Cold adaptation of parainfluenza virus type 3: induction of three phenotypic markers. J. Med. Virol. 10:1982;235-242.
5. Brown E.G., Wright K.E. Genetic studies on a mumps vaccine strain associated with meningitis. Rev. Med. Virol. 8:1998;129-142.
6. Brown E.G., Furesz J., Dimock K., Yarosh W., Contreras G. Nucleotide sequence analysis of the Urabe mumps vaccine strain that caused meningitis in vaccine recipients. Vaccine. 9:1991;840-842.
7. Brown E.G., Dimock K., Wright K.E. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J. Infect. Dis. 174:1996;619-622.
8. Crookshanks F.K., Belshe R.B. Evaluation of cold adapted and temperature sensitive mutants of parainfluenza virus type 3 in weanling hamsters. J. Med. Virol. 13:1984;243-249.
9. Crowe J.E. Jr, Bui P.T., Davis A.R., Chanock R.M., Murphy B.R. A further attenuated derivative of a cold-passaged temperature sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Vaccine. 12:1994;783-790.
10. Cusi M.G., Santini L., Bianchi S., Valassina M., Valensin P.E. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in wild-type strains of mumps virus is the most relevant marker of virulence. J. Clin. Microbiol. 36:1998;3743-3744.
11. Firestone C.-Y., Whiteheade S.S., Collins P.L., Murphy B.R., Crowe J.E. Jr. Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate. Virology. 225:1996;419-422.
12. Forsey T., Mawn J.A., Yates P.J., Bentley M.L., Minor P.D. Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxynucleotide sequencing. J. Gen. Virol. 71:1990;987-990.
13. Hall S.L., Stokes A., Tierney E.L., London W.T., Belshe R.B., Newman C., Murphy B.R. Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys. Virus Res. 22:1992;173-184.
14. Kövamees J., Norrby E., Elango N. Complete nucleotide sequence of the hemagglutinin-neuraminidase (HN) mRNA of mumps virus and comparison of paramyxovirus HN proteins. Virus Res. 12:1989;87-96.
15. Kövamees J., Rydbeck R., Orvell C., Norrby E. Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res. 17:1990;119-130.
16. Merz D.C., Wolinsky J.S. Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein. Virology. 131:1983;328-340.
17. Ogino T., Kotake S., Yoshida T.O. Persistent infection of mouse tumor cells with mumps virus. Biken J. 23:1980;15-24.
18. Orvell C. The reactions of monoclonal antibodies with structural proteins of mumps virus. J. Immunol. 132:1984;2622-2629.
19. Ray R., Galinski M.S., Neminway B.R., Meyer K., Newman F.K., Belshe R.B. Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene. J. Virol. 70:1996;580-584.
20. Rubin S.A., Snoy P.J., Wright K.E., Brown E.G., Reeve P., Beeler J., Carbone K.M. The mumps neurovirulence safety test in rhesus monkeys: a comparison of mumps virus strains. J. Infect. Dis. 180:1999;521-525.
21. Server A.C., Merz D.C., Waxham M.N., Wolinsky J.S. Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein. Infect. Immun. 35:1982;179-186.
22. Skiadopoulos M.H., Durbin A.P., Tatem J.M., Wu S.L., Paschalis M., Tao T., Collins P.L., Murphy B.R. Three amino acid substitutions in the L protein of the human parainfluenza virus type 2 cp45 live attenuated vaccine candidate contribute to its temperature sensitive and attenuation phenotypes. J. Virol. 72:1998;1762-1768.
23. Sosin D.M., Cochi S.L., Gunn R.A., Jennings C.E., Preblud S.R. Changing epidemiology of mumps and its impact on university campuses. Pediatrics. 84:1989;779-784.
24. Takeuchi K., Tahabayashi K., Hishiyama M., Yamada A., Sugiura A. Cloning and sequencing of the hemagglutinin-neuraminidase gene of mumps virus (Miyahara strain). Nucleic Acid Res. 17:1989;5840.
25. Tanabayashi K., Takeuchi K., Okasaki K., Hishiyama M., Yamada A. Identification of an amino acid that defines the fusogenicity of mumps virus. J. Virol. 67:1993;2928-2931.
26. Truant A.L., Hallum J.V. A persistent infection of baby hamster kidney-21 cells with mumps virus and the role of temperature-sensitive variants. J. Med. Virol. 1:1977;49-67.
27. Waxham M.N., Aronowski J. Identification of amino acids involved in the sialidase activity of the mumps hemagglutinin-neuraminidase protein. Virology. 167:1988;226-232.
28. Waxham M.N., Wolinsky J.S. A fusing mumps virus variant selected from a nonfusing parent with the neuraminidase inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology. 151:1986;286-295.
29. Yamanishi K., Takahashi M., Ueda S., Minekawa Y., Ogino T., Suzuki N., Okuno Y. Studies on live mumps virus vaccine. V. Development of a new mumps vaccine 'AM9' by plaque cloning. Biken J. 16:1973;161-166.
30. Yates P.J., Afzal M.A., Minor P.D. Antigenic and genetic variation of the HN proteins of mumps virus strains. J. Gen. Virol. 77:1996;2491-2497.